This intensive one-year fellowship is designed to prepare physicians for academic careers focused on transplantation and cellular therapy. Our program started in the late 1960s with Nobel prize winner, E. Donnall Thomas, and his team of transplant physicians and clinical staff, who discovered a way to treat advanced leukemia by eradicating malignant white blood cells in the bone marrow using high doses of chemotherapy and radiation, and then replacing them with healthy donor cells. We now have 60 clinical faculty members at Fred Hutch and the University of Washington who specialize in transplantation and cellular therapy and serve as mentors to trainees from around the world.
The BMT and Immunotherapy fellowship is an intense, year-long program to prepare hematology-oncology physicians to become adept in blood and marrow transplantation (BMT) and immunotherapy (IMTX) services.
You will have the opportunity to work with world renowned faculty who are on the cutting edge of novel treatments for malignant and non-malignant diseases. The fellow will rotate through outpatient and inpatient BMT (autologous and allogeneic, long-term follow-up) and IMTX services, and initially function as a primary care provider with increasing levels of patient care responsibility over the course of the year. Approximately 8 months will be devoted to clinical activities with the remaining time available to participate in research projects.
The application system is currently accepting materials for the July 2024-June 2025 academic year. Application links found below.
Professor
Clinical Research Division, Fred Hutch
Medical Director
Adult Blood and Marrow Transplantation,
Fred Hutch
Professor
Clinical Research Division, Fred Hutch
Medical Director
Cellular Immunotherapy, Immunotherapy Integrated Research Center (IIRC), Fred Hutch
Leonard and Norma Klorfine Endowed Chair for Clinical Research, Fred Hutch
Section Head, Hematologic Malignancies
Clinical Research Division, Fred Hutch
Professor and Associate Director
Clinical Research Division, Fred Hutch
David and Patricia Giuliani/Oliver Press Endowed Chair in Cancer Research, Fred Hutch
Assistant Professor Clinical Research Division, Fred Hutch
Assistant Professor Division of Medical Oncology University of Washington School of Medicine
Assistant Medical Director Inpatient Blood and Marrow Transplantation
Fred Hutch
Senior Vice President and Director
Translational Sciences and Therapeutics Division, Fred Hutch
Scientific Director
Immunotherapy Integrated Research Center (IIRC), Fred Hutch
Director of Hematopoietic Stem Cell Transplantation
Fred Hutch
José Carreras / E. Donnall Thomas Endowed Chair for Cancer Research, Fred Hutch
The application system is currently accepting materials for the July 2024-June 2025 academic year.
We believe that the diversity of our fellows, residents, medical students, staff and faculty is a fundamental element of our ability to ensure that all our patients and families receive the highest-quality care – no matter their race, ethnicity, language, literacy, age, gender, gender identity, sexual orientation, religion, disability or finances. Our objective is to create a community that encourages participation and connection, and that values and includes each individual's unique contribution, in every aspect of our mission and practice.
Anne Nguyen
Administrative Manager, CRD Administration